A group of lab technicians work in Jakarta's main TB hospital.

Indonesia has one of the heaviest TB burdens in the world, and COVID-19 threatens to make things worse. The Global Fund has worked closely with partners and the government to test and treat millions of people across Indonesia, including testing 564,000 people in 2018 alone. Investments from the Global Fund also support the purchase of GeneXpert machines – molecular diagnostic instruments that have revolutionized TB control by providing swift turnaround of test results. With support from the Global Fund, over 800 of these machines have been installed in health facilities across the country.